Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Risedronate is in a class of drugs called bisphosphonates used for the treatment of Paget's disease of bone (in which the formation of bone is abnormal) and in persons with osteoporosis (in which the density and strength of bones are reduced).
The report details the trend, potential and market size of Risedronate market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Risedronatemarket, defines the market attractiveness level of Risedronate market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Risedronate industry, describes the types of Risedronate market, the applications of major players and the market size, and deeply analyzes the current situation of the global Risedronate market and the development prospects and opportunities of Risedronate industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Risedronate market in Chapter 13.
By Player:
Merck
Tecoland
Sanofi
Amgen
Teva
Apotex
Taj Pharmaceuticals
Mylan
Novartis
Abbott
By Type:
5 mg Tablets
35 mg Tablets
75 mg Tablets
150 mg Tablets
By End-User:
Postmenopausal Osteoporosis
Men with Osteoporosis
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Risedronate Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Risedronate Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Risedronate Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Risedronate Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Risedronate Market Analysis and Outlook to 2022
-
7.1 Global Risedronate Consumption (2017-2022)
-
7.2 United States Risedronate Consumption (2017-2022)
-
7.3 Europe Risedronate Consumption (2017-2022)
-
7.4 China Risedronate Consumption (2017-2022)
-
7.5 Japan Risedronate Consumption (2017-2022)
-
7.6 India Risedronate Consumption (2017-2022)
-
7.7 South Korea Risedronate Consumption (2017-2022)
8 Region and Country-wise Risedronate Market Analysis and Outlook to 2028
-
8.1 Global Risedronate Consumption Forecast (2022-2028)
-
8.2 United States Risedronate Consumption Forecast (2022-2028)
-
8.3 Europe Risedronate Consumption Forecast (2022-2028)
-
8.4 China Risedronate Consumption Forecast (2022-2028)
-
8.5 Japan Risedronate Consumption Forecast (2022-2028)
-
8.6 India Risedronate Consumption Forecast (2022-2028)
-
8.7 South Korea Risedronate Consumption Forecast (2022-2028)
9 Global Risedronate Market Outlook by Types and Applications to 2022
-
9.1 Global Risedronate Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 5 mg Tablets Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 35 mg Tablets Consumption and Growth Rate (2017-2022)
-
9.1.3 Global 75 mg Tablets Consumption and Growth Rate (2017-2022)
-
9.1.4 Global 150 mg Tablets Consumption and Growth Rate (2017-2022)
-
9.2 Global Risedronate Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Postmenopausal Osteoporosis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Men with Osteoporosis Consumption and Growth Rate (2017-2022)
10 Global Risedronate Market Outlook by Types and Applications to 2028
-
10.1 Global Risedronate Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 5 mg Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 35 mg Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global 75 mg Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global 150 mg Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Risedronate Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Postmenopausal Osteoporosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Men with Osteoporosis Consumption Forecast and Growth Rate (2022-2028)
11 Global Risedronate Import and Export Analysis (Top 5 Countries)
-
11.1 Global Risedronate Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Risedronate Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Risedronate Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Risedronate Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck Risedronate Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck Risedronate Product and Service
-
14.2 Tecoland
-
14.2.1 Tecoland Company Details
-
14.2.2 Tecoland Risedronate Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Tecoland Risedronate Product and Service
-
14.3 Sanofi
-
14.3.1 Sanofi Company Details
-
14.3.2 Sanofi Risedronate Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sanofi Risedronate Product and Service
-
14.4 Amgen
-
14.4.1 Amgen Company Details
-
14.4.2 Amgen Risedronate Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Amgen Risedronate Product and Service
-
14.5 Teva
-
14.5.1 Teva Company Details
-
14.5.2 Teva Risedronate Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Teva Risedronate Product and Service
-
14.6 Apotex
-
14.6.1 Apotex Company Details
-
14.6.2 Apotex Risedronate Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Apotex Risedronate Product and Service
-
14.7 Taj Pharmaceuticals
-
14.7.1 Taj Pharmaceuticals Company Details
-
14.7.2 Taj Pharmaceuticals Risedronate Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Taj Pharmaceuticals Risedronate Product and Service
-
14.8 Mylan
-
14.8.1 Mylan Company Details
-
14.8.2 Mylan Risedronate Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Mylan Risedronate Product and Service
-
14.9 Novartis
-
14.9.1 Novartis Company Details
-
14.9.2 Novartis Risedronate Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Novartis Risedronate Product and Service
-
14.10 Abbott
-
14.10.1 Abbott Company Details
-
14.10.2 Abbott Risedronate Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Abbott Risedronate Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Risedronate
-
Figure Risedronate Picture
-
Table Global Risedronate Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Risedronate Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Risedronate Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Risedronate Consumption by Country (2017-2022)
-
Figure United States Risedronate Consumption and Growth Rate (2017-2022)
-
Table Europe Risedronate Consumption and Growth Rate (2017-2022)
-
Figure China Risedronate Consumption and Growth Rate (2017-2022)
-
Figure Japan Risedronate Consumption and Growth Rate (2017-2022)
-
Figure India Risedronate Consumption and Growth Rate (2017-2022)
-
Figure South Korea Risedronate Consumption and Growth Rate (2017-2022)
-
Figure Global Risedronate Consumption Forecast by Country (2022-2028)
-
Figure United States Risedronate Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Risedronate Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Risedronate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Risedronate Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Risedronate Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Risedronate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 5 mg Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global 35 mg Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global 75 mg Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global 150 mg Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global Postmenopausal Osteoporosis Consumption and Growth Rate (2017-2022)
-
Figure Global Men with Osteoporosis Consumption and Growth Rate (2017-2022)
-
Figure Global 5 mg Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 35 mg Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 75 mg Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 150 mg Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Postmenopausal Osteoporosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Men with Osteoporosis Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Risedronate Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Risedronate Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Risedronate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Risedronate Product and Service
-
Table Tecoland (Foundation Year, Company Profile and etc.)
-
Table Tecoland Risedronate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tecoland Risedronate Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Risedronate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Risedronate Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Risedronate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Risedronate Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Risedronate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Risedronate Product and Service
-
Table Apotex (Foundation Year, Company Profile and etc.)
-
Table Apotex Risedronate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Apotex Risedronate Product and Service
-
Table Taj Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Taj Pharmaceuticals Risedronate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Taj Pharmaceuticals Risedronate Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Risedronate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Risedronate Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Risedronate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Risedronate Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Risedronate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Risedronate Product and Service
-
